News & Analysis on Clinical Trial Services & Contract Research And Development
Kreatech Biotechnology launches a series of nucleic acid labelling kits for in situ hybridisation and filter hybridisation applications. These kits offer the researcher the possibility to non enzymatically label their target nucleic acid of choice,...
German biotech company, Orthogen, has presented a study that has shown the emergence of autologous bioengineered proteins as a viable alternative to the cox-II inhibitor class. The class of drug was blighted with severe side effects, which resulted in...
Tripos introduces its LeadDiscovery program to accelerate the drug discovery process. The new program offers a method to develop novel preclinical compounds for customers in the pharmaceutical and biotechnology industry.